Table 2.

Surgical performance and perioperative outcome of pelvic exenteration.

Characteristic	All	2001–2005	2006–2010	2011–2015	P-value
Number	N = 2647	n = 716	n = 994	n = 937
Lymphadenectomy					<0.001
No	1463 (55.3%)	331 (46.2%)	552 (55.5%)	579 (61.9%)
Yes	1184 (44.7%)	385 (53.8%)	442 (44.5%)	357 (38.1%)
Colostomy					<0.001
No	987 (37.3%)	290 (40.5%)	413 (41.5%)	285 (30.4%)
Yes	1659 (62.7%)	426 (59.5%)	581 (58.5%)	652 (69.6%)
Urinary diversion					<0.001
No	707 (26.7%)	233 (32.5%)	271 (27.3%)	203 (21.7%)
Yes	1940 (73.3%)	483 (67.5%)	723 (72.7%)	734 (78.3%)
Vaginal reconstruction					0.350
No	2055 (77.7%)	561 (78.4%)	781 (78.7%)	713 (76.1%)
Yes	591 (22.3%)	155 (21.6%)	212 (21.3%)	224 (23.9%)
Complication (any)					<0.001
0	845 (31.9%)	299 (41.8%)	351 (35.3%)	195 (20.8%)
1	779 (29.4%)	206 (28.8%)	325 (32.7%)	248 (26.5%)
2	426 (16.1%)	127 (17.7%)	111 (11.2%)	188 (20.1%)
≥3	597 (22.6%)	84 (11.7%)	207 (20.7%)	306 (32.7%)
Death					**
No	2598 (98.1%)	709 (99.0%)	967 (97.3%)	922 (98.4%)
Yes	49 (1.9%)	*	27 (2.7%)	15 (1.6%)
Length of stay (day)
<28	2205 (83.3%)	626 (87.4%)	821 (82.6%)	758 (80.9%)
≥28	442 (16.7%)	90 (12.6%)	173 (17.4%)	179 (19.1%)	0.001
Total charge (crude)	$119,274 (IQR 75,484–203,744)	$81,732 (IQR 51,368–190,189)	$120,581 (IQR78,118–290,591)	$177,095 (IQR101,341–264,317)	<0.001
Total charge (corrected)†	$146,366 (IQR 94,655–236,040)	$121,854 (IQR 78,632–172,350)	$146,332 (IQR 98,539–232,101)	$185,100 (IQR 106,665–282,394)	<0.001

Median (IQR) or number (percent per column) is shown. Kruskal-Wallis H test or chi-square test for P-values. Significant P-values are emboldened.

^*indicated number of ≤10, required to suppress per the Healthcare Cost and Utilization Project.

^**not assessed due to suppressed number.

^†converted to 2015 value based on medical inflation rate (Table S2).